| P50 | author | Irene M Lang | Q87931178 |
| | Christian Hengstenberg | Q28036480 |
| | Marcus Hacker | Q28149000 |
| | Jolanta M Siller-Matula | Q37837348 |
| P2093 | author name string | Renate Kain | |
| | Martin Andreas | |
| | Georg Goliasch | |
| | Christina Binder | |
| | Dietrich Beitzke | |
| | Matthias Schneider | |
| | Christian Loewe | |
| | Alexander Geppert | |
| | Diana Bonderman | |
| | Hermine Agis | |
| | Julia Mascherbauer | |
| | Stefan Aschauer | |
| | Franz Duca | |
| | Christian Nitsche | |
| | Matthias Koschutnik | |
| | Max-Paul Winter | |
| | Anahit Anvari-Pirsch | |
| | Andreas A Kammerlander | |
| | Thomas Poschner | |
| | Julian Stiftinger | |
| P2860 | cites work | Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. | Q48771344 |
| | Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement. | Q49494490 |
| | Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement | Q50093215 |
| | Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. | Q50622497 |
| | Cardiac amyloidosis as a potential risk factor for transapical transcatheter aortic valve implantation. | Q51153147 |
| | Amyloid in the heart: an under-recognized threat at the interface of cardiology, haematology, and pathology. | Q51663167 |
| | Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. | Q52398402 |
| | Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. | Q52429603 |
| | Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy | Q56340333 |
| | Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis | Q61657843 |
| | Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis | Q62083154 |
| | Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation | Q70561767 |
| | Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy | Q80833658 |
| | Daratumumab proves safe and highly effective in AL amyloidosis | Q89230085 |
| | Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week | Q91382327 |
| | Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment | Q26827340 |
| | Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols | Q30441384 |
| | European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). | Q33550673 |
| | Primary systemic amyloidosis: clinical and laboratory features in 474 cases. | Q34320169 |
| | The global burden of aortic stenosis | Q34420441 |
| | Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction | Q34487487 |
| | Assessment of myocardial fibrosis with cardiovascular magnetic resonance | Q34846884 |
| | Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method | Q36233097 |
| | Recommendations for the standardization and interpretation of the electrocardiogram: part I: the electrocardiogram and its technology a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council o | Q36756411 |
| | (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses | Q37054790 |
| | Pathophysiology and treatment of cardiac amyloidosis | Q38259728 |
| | Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. | Q38364873 |
| | Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement | Q38411685 |
| | Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. | Q38414834 |
| | AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy | Q38955782 |
| | Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy | Q40388294 |
| | Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study | Q40425042 |
| | T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication | Q41036082 |
| | A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. | Q44254874 |
| | Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis | Q47128372 |
| P577 | publication date | 2020-02-20 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome | |